Free Trial

Flora Growth (FLGC) Competitors

$1.15
-0.09 (-7.26%)
(As of 05/31/2024 ET)

FLGC vs. OCC, CELU, RPHM, THTX, MURA, AEON, CARM, IMMX, ANEB, and RMTI

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Optical Cable (OCC), Celularity (CELU), Reneo Pharmaceuticals (RPHM), Theratechnologies (THTX), Mural Oncology (MURA), AEON Biopharma (AEON), Carisma Therapeutics (CARM), Immix Biopharma (IMMX), Anebulo Pharmaceuticals (ANEB), and Rockwell Medical (RMTI).

Flora Growth vs.

Flora Growth (NASDAQ:FLGC) and Optical Cable (NASDAQ:OCC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.

In the previous week, Flora Growth had 1 more articles in the media than Optical Cable. MarketBeat recorded 3 mentions for Flora Growth and 2 mentions for Optical Cable. Optical Cable's average media sentiment score of 1.59 beat Flora Growth's score of 0.63 indicating that Optical Cable is being referred to more favorably in the news media.

Company Overall Sentiment
Flora Growth Positive
Optical Cable Very Positive

Flora Growth has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Comparatively, Optical Cable has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.

36.0% of Flora Growth shares are held by institutional investors. Comparatively, 13.6% of Optical Cable shares are held by institutional investors. 17.6% of Flora Growth shares are held by insiders. Comparatively, 23.0% of Optical Cable shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Optical Cable has lower revenue, but higher earnings than Flora Growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flora Growth$76.07M0.19-$57.04MN/AN/A
Optical Cable$72.17M0.31$2.07M-$0.03-93.97

Flora Growth presently has a consensus target price of $6.00, suggesting a potential upside of 421.74%. Given Flora Growth's higher probable upside, analysts clearly believe Flora Growth is more favorable than Optical Cable.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flora Growth
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Optical Cable
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Optical Cable received 90 more outperform votes than Flora Growth when rated by MarketBeat users. Likewise, 64.60% of users gave Optical Cable an outperform vote while only 60.87% of users gave Flora Growth an outperform vote.

CompanyUnderperformOutperform
Flora GrowthOutperform Votes
14
60.87%
Underperform Votes
9
39.13%
Optical CableOutperform Votes
104
64.60%
Underperform Votes
57
35.40%

Optical Cable has a net margin of -0.24% compared to Flora Growth's net margin of -75.95%. Optical Cable's return on equity of -6.09% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Flora Growth-75.95% -144.44% -43.20%
Optical Cable -0.24%-6.09%-3.45%

Summary

Optical Cable beats Flora Growth on 9 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$14.74M$6.72B$5.11B$7.97B
Dividend YieldN/A2.68%2.75%4.00%
P/E RatioN/A10.98120.3615.18
Price / Sales0.19407.182,428.4593.40
Price / CashN/A32.8835.0431.51
Price / Book4.796.085.524.59
Net Income-$57.04M$138.60M$105.88M$213.90M
7 Day Performance-11.54%3.29%1.13%0.87%
1 Month Performance-32.75%1.09%1.42%3.60%
1 Year Performance-73.99%-1.29%4.04%7.91%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCC
Optical Cable
0 of 5 stars
$2.82
+0.7%
N/A-29.3%$21.99M$72.17M-93.97327Short Interest ↓
Positive News
Gap Up
CELU
Celularity
0 of 5 stars
$3.11
+4.4%
N/A-59.1%$57.75M$17.98M0.00225Upcoming Earnings
Short Interest ↑
RPHM
Reneo Pharmaceuticals
2.2133 of 5 stars
$1.66
-3.5%
$11.01
+563.4%
-79.3%$57.48MN/A-0.768Short Interest ↑
THTX
Theratechnologies
0 of 5 stars
$1.25
flat
N/A-67.1%$57.47M$81.76M-2.05103Positive News
MURA
Mural Oncology
2.6251 of 5 stars
$3.36
+0.3%
$13.00
+286.9%
N/A$56.69MN/A0.00119Short Interest ↓
Positive News
AEON
AEON Biopharma
1.4439 of 5 stars
$1.58
+9.7%
$6.00
+279.7%
N/A$56.34MN/A0.0010Analyst Forecast
CARM
Carisma Therapeutics
2.7407 of 5 stars
$1.33
+1.5%
$9.00
+576.7%
-76.5%$55.25M$15.07M-0.67107Short Interest ↓
Positive News
IMMX
Immix Biopharma
3.3539 of 5 stars
$2.11
+1.0%
$14.00
+563.5%
+4.5%$55.21MN/A-2.2714Short Interest ↓
Positive News
Gap Up
ANEB
Anebulo Pharmaceuticals
2.6859 of 5 stars
$2.05
-2.4%
$6.67
+225.2%
-9.3%$54.46MN/A-5.542Short Interest ↓
News Coverage
Positive News
Gap Down
RMTI
Rockwell Medical
3.8901 of 5 stars
$1.76
-1.1%
$7.00
+298.9%
-47.1%$53.66M$83.61M-4.87237

Related Companies and Tools

This page (NASDAQ:FLGC) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners